Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease. Issue 1 (24th January 2019)

• Record Type: Journal Article
• Authors: Taverner, John; Ross, Lauren; Bartlett, Claire; Luthe, Marco; Ong, Jeffrey; Irving, Louis; Smallwood, Natasha
• Is Part Of: Internal medicine journal. Volume 49:Issue 1(2019)
• Page Start: 66
• Page End: 73
• Publication Date: 2019-01-24
• Subjects: COPD -- antimicrobial -- antibiotic -- palliative care -- antimicrobial stewardship -- guideline adherence; Medicine -- Periodicals; 616
• DOI: 10.1111/imj.13959
• Languages: English
• ISSNs: 1444-0903

Abstract

Abstract: Background: Despite rising antimicrobial resistance, treatment guidelines for chronic obstructive pulmonary disease (COPD) exacerbations are frequently ignored. Patients with terminal conditions are often prescribed antimicrobials despite the goal of care to reduce burdensome treatments. The appropriate use of antimicrobials in patients who die from an exacerbation of COPD is unknown. Aim: To review antimicrobial prescription during the final admission in patients who died from an acute exacerbation of COPD. Methods: A retrospective medical record audit was performed for 475 patients who died over 12 years (2004–2015). Patients were analysed within three groups: Group 1 – pneumonia on chest radiograph, Group 2 – infective exacerbation of COPD +/− raised inflammatory markers (white cell count, C‐reactive protein) and Group 3 – non‐infective exacerbation of COPD. Results: A total of 221 patients died from COPD. The median age was 80 years, and 136 (60%) were male. Median respiratory function: forced expiratory volume in 1 s 0.8 L (41.0%), forced vital capacity 2.0 L (74.0%) and diffusing capacity for carbon monoxide 8 (40.5%). A total of 109 (49.3%) patients used home oxygen and 156 (70.6%) were ex‐smokers. Of the cohort, 90.5% received antimicrobials. In Groups 1, 2 and 3, 68 (94.4%), 108 (92.3%) and 24 (75.0%) patients received antimicrobials respectively. Guideline‐concordant therapy was administered to 31.7% of patients (Group 1: 79.2%, Group 2: 4.3%, Group 3: 25.0%), 60.2% of patients received ceftriaxone and 44.8% received azithromycin. The median duration of therapy was 4 days and 27.1% received antimicrobials at the time of death. Conclusion: Antimicrobials are overprescribed, and non‐guideline antimicrobials are overused in patients who die from COPD. Further education of medical staff, regular medication reviews and the use of disease severity scores or clinical pathways may improve antimicrobial stewardship.